TORNTPHARM.NSTORNTPHARM.NS
LOADING
|||
Revenue Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
2.14%
↑ 22% above average
Average (39q)
1.76%
Historical baseline
Range
High:13.06%
Low:-8.99%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 2.14% |
| Q2 2025 | 7.40% |
| Q1 2025 | 5.34% |
| Q4 2024 | -2.77% |
| Q3 2024 | 1.05% |
| Q2 2024 | 4.16% |
| Q1 2024 | 0.47% |
| Q4 2023 | 2.71% |
| Q3 2023 | 2.66% |
| Q2 2023 | 4.01% |
| Q1 2023 | 0.01% |
| Q4 2022 | 8.73% |
| Q3 2022 | -2.39% |
| Q2 2022 | 10.24% |
| Q1 2022 | 1.00% |
| Q4 2021 | -1.36% |
| Q3 2021 | 0.14% |
| Q2 2021 | 10.19% |
| Q1 2021 | -2.93% |
| Q4 2020 | -1.09% |
| Q3 2020 | -1.90% |
| Q2 2020 | 5.64% |
| Q1 2020 | -1.00% |
| Q4 2019 | -1.95% |
| Q3 2019 | -0.84% |
| Q2 2019 | 5.38% |
| Q1 2019 | -3.48% |
| Q4 2018 | 4.96% |
| Q3 2018 | 1.18% |
| Q2 2018 | 12.11% |
| Q1 2018 | 13.06% |
| Q4 2017 | 3.36% |
| Q3 2017 | 4.00% |
| Q2 2017 | -1.34% |
| Q1 2017 | -3.49% |
| Q4 2016 | 0.98% |
| Q3 2016 | -7.51% |
| Q2 2016 | 3.70% |
| Q1 2016 | -3.19% |
| Q4 2015 | -8.99% |